Today: 30 April 2026
AI stock slips again as Anthropic’s ‘Cowork’ puts C3.ai back in focus
15 January 2026
1 min read

AI stock slips again as Anthropic’s ‘Cowork’ puts C3.ai back in focus

New York, January 15, 2026, 13:32 ET — Regular session

  • C3.ai shares slipped roughly 0.8% in afternoon trading, erasing part of Wednesday’s bounce.
  • William Blair’s analyst pointed out that Anthropic’s new “Cowork” tool dents sentiment around software stocks, but doesn’t affect the fundamentals.
  • Investors are gearing up for C3.ai’s upcoming earnings report, slated for late February.

C3.ai’s shares slipped roughly 0.8% on Thursday, erasing part of the previous day’s rally as investors reevaluated software firms tied to the rapidly evolving AI tools market. Early afternoon trading saw the stock at $13.80.

The newest pressure point is “agentic” software—AI that can operate across files and apps, not just respond to prompts. Anthropic is previewing a product called Cowork, targeting non-coders. Axios reported it’s currently limited to Claude Max users on macOS. Axios

William Blair analyst Arjun Bhatia weighed in Thursday, calling the market’s reaction to public software stocks “overstated.” He said the launch of Claude Cowork introduces another sentiment drag but isn’t a fundamental threat. Cowork, a premium upgrade linked to Anthropic’s Claude Max plan, starts at $100 per user per month, according to the report. Investors

C3.ai shares climbed 2.58% on Wednesday, closing at $13.91 and outpacing the broader market’s weaker performance. Still, the stock sits over 60% below its 52-week peak of $35.98, reached on Feb. 10.

The rebound came after a steep 4.17% fall on Tuesday, with shares closing at $13.56, ending a three-day run of gains.

The bigger question now is whether frontier model creators like Anthropic and OpenAI end up as partners or rivals to enterprise software vendors. RBC Capital Markets analysts, in a research note highlighted by Business Insider, pointed out that Anthropic’s recent product launches lined up with a selloff in stocks like Salesforce, Workday, and Snowflake. They cautioned that “the velocity of innovation and announcements from the model providers could continue to weigh” on the software sector through 2026. Business Insider

C3.ai, a provider of enterprise AI application software, posted $75.1 million in total revenue in its latest quarter. The company also reported holding $675.0 million in cash, cash equivalents, and marketable securities. CEO Stephen Ehikian highlighted that the quarter’s momentum came mainly from its federal business, noting, “The Federal market continues to be a large growth vector for us.” C3 AI

The downside risk remains for the stock. Should customers favor the major model providers more aggressively for workflow automation, smaller vendors could be squeezed by tougher pricing, extended sales cycles, and increased costs just to stay competitive — all factors that can quickly impact high-volatility stocks.

C3.ai is set to release its next earnings report around Feb. 25, per Zacks. Investors will focus on bookings and any changes to the company’s guidance on losses and growth during that update.

Stock Market Today

  • Why Investors Are Focused on Vaidya Sane Ayurved Laboratories (NSE:MADHAVBAUG) Amid Growth and High Insider Ownership
    April 29, 2026, 10:29 PM EDT. Vaidya Sane Ayurved Laboratories (NSE:MADHAVBAUG) has attracted investor attention due to its strong financial performance and insider alignment. The company has delivered a compound annual EPS growth of 19% over the past three years, signaling sustained earnings momentum. Revenue growth and an improved EBIT margin, up by 6.6 percentage points to 11%, underscore operational strength. With insiders owning 78% of the firm, alignment between management and shareholders is notably high, reducing agency risk. Valued at ₹2.5 billion, the company appeals to investors favoring profitable, growing firms over speculative ventures without revenue or profit history. This combination of growth, profitability, and insider confidence makes Vaidya Sane a compelling pick in the Ayurvedic healthcare sector.

Latest article

Soluna Holdings Stock Jumps After Sazmining Bitcoin Deal, Then SEC Resale Filing Lands

Soluna Holdings Stock Jumps After Sazmining Bitcoin Deal, Then SEC Resale Filing Lands

30 April 2026
Soluna Holdings filed to register the resale of about 2.46 million common shares, with no proceeds going to the company. The move follows Sazmining’s launch of a 3-megawatt Bitcoin mining operation at Soluna’s Project Dorothy 1B in West Texas. Soluna shares last traded at $1.28, up from a $1.08 Nasdaq sale price on April 28. The registered shares include 2.4 million issuable to YA II PN, LTD. via warrant exercise.
Brookfield Renewable Stock Drops 12% Before Q1 Results as BEPC Investors Brace for Friday

Brookfield Renewable Stock Drops 12% Before Q1 Results as BEPC Investors Brace for Friday

30 April 2026
Brookfield Renewable Corp’s NYSE shares fell 12.5% to $35.20 on Wednesday, with volume quadrupling the three-month average ahead of first-quarter results due Friday. The drop came despite a higher quarterly dividend and mixed analyst views. The company operates 47 GW of clean energy assets globally. Analysts expect a first-quarter loss of 33.92 cents per share on $1.62 billion in revenue.
XRP stock slides as Senate delays key crypto bill vote; what traders watch next
Previous Story

XRP stock slides as Senate delays key crypto bill vote; what traders watch next

American Express stock barely budges after fresh loan data — what AXP investors are watching next
Next Story

American Express stock barely budges after fresh loan data — what AXP investors are watching next

Go toTop